Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
Jefferies to hold a virtual conference » 04:55
11/19/20
11/19
04:55
11/19/20
04:55
MRNA

Moderna

$88.90 /

-4.225 (-4.54%)

, IMGN

ImmunoGen

$5.75 /

-0.035 (-0.61%)

, ESPR

Esperion

$29.18 /

-0.95 (-3.15%)

, CRL

Charles River

$234.11 /

-2.205 (-0.93%)

, AXGN

AxoGen

$15.16 /

-0.05 (-0.33%)

, INMD

InMode

$42.75 /

+0.16 (+0.38%)

, PRTA

Prothena

$12.10 /

-0.24 (-1.94%)

, SYNH

Syneos Health

$63.21 /

-0.24 (-0.38%)

, RDNT

RadNet

$18.19 /

-0.75 (-3.96%)

, OPNT

Opiant Pharmaceuticals

$7.95 /

+0.2 (+2.58%)

, FGEN

FibroGen

$41.56 /

-2.58 (-5.85%)

, MGLN

Magellan Health

$82.25 /

-2.47 (-2.92%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

, CARA

Cara Therapeutics

$15.66 /

-0.53 (-3.27%)

, IVA

Inventiva

$14.00 /

+ (+0.00%)

, ITOS

iTeos Therapeutics

$25.09 /

+1.14 (+4.76%)

, CLBS

Caladrius

$1.44 /

-0.055 (-3.68%)

, ALNA

Allena Pharmaceuticals

$1.37 /

-0.07 (-4.86%)

, SEEL

Seelos Therapeutics

$0.78 /

-0.0296 (-3.65%)

, SMMNY

Siemens Healthineers

$0.00 /

+ (+0.00%)

, CNCE

Concert Pharmaceuticals

$10.82 /

-0.23 (-2.08%)

Virtual Healthcare…

Virtual Healthcare Conference will be held on November 17-19.

ShowHide Related Items >><<
SYNH Syneos Health
$63.21 /

-0.24 (-0.38%)

SMMNY Siemens Healthineers
$0.00 /

+ (+0.00%)

SEEL Seelos Therapeutics
$0.78 /

-0.0296 (-3.65%)

RHHBY Roche
$0.00 /

+ (+0.00%)

RDNT RadNet
$18.19 /

-0.75 (-3.96%)

PRTA Prothena
$12.10 /

-0.24 (-1.94%)

OPNT Opiant Pharmaceuticals
$7.95 /

+0.2 (+2.58%)

MRNA Moderna
$88.90 /

-4.225 (-4.54%)

MGLN Magellan Health
$82.25 /

-2.47 (-2.92%)

IVA Inventiva
$14.00 /

+ (+0.00%)

ITOS iTeos Therapeutics
$25.09 /

+1.14 (+4.76%)

INMD InMode
$42.75 /

+0.16 (+0.38%)

IMGN ImmunoGen
$5.75 /

-0.035 (-0.61%)

FGEN FibroGen
$41.56 /

-2.58 (-5.85%)

ESPR Esperion
$29.18 /

-0.95 (-3.15%)

CRL Charles River
$234.11 /

-2.205 (-0.93%)

CNCE Concert Pharmaceuticals
$10.82 /

-0.23 (-2.08%)

CLBS Caladrius
$1.44 /

-0.055 (-3.68%)

CARA Cara Therapeutics
$15.66 /

-0.53 (-3.27%)

AXGN AxoGen
$15.16 /

-0.05 (-0.33%)

ALNA Allena Pharmaceuticals
$1.37 /

-0.07 (-4.86%)

MRNA Moderna
$88.90 /

-4.225 (-4.54%)

11/17/20 Benchmark
Inovio on 'top-10 vaccine contenders list,' says Benchmark
11/17/20 Maxim
Co-Diagnostics price target lowered to $20 from $30 at Maxim
11/17/20 Roth Capital
Inovio downgraded to Sell at Roth Capital on increased competition
11/17/20 Redburn
Moderna initiated with a Sell at Redburn
IMGN ImmunoGen
$5.75 /

-0.035 (-0.61%)

10/26/20 H.C. Wainwright
ImmunoGen assumed with a Buy at H.C. Wainwright
10/19/20 Piper Sandler
Greater China partnership 'very favorable' for ImmunoGen, says Piper Sandler
10/05/20 Piper Sandler
Piper says r/r BPDCN revenue opportunity for ImmunoGen's 632 'an open question'
10/02/20 Guggenheim
ImmunoGen upgraded to Buy from Neutral at Guggenheim
ESPR Esperion
$29.18 /

-0.95 (-3.15%)

11/10/20 Credit Suisse
Esperion upgraded to Outperform from Neutral at Credit Suisse
09/29/20 JPMorgan
Esperion resumed with an Underweight at JPMorgan
08/10/20 Credit Suisse
Esperion downgraded to Neutral from Outperform at Credit Suisse
05/07/20 Citi
Esperion price target raised to $56 from $46 at Citi
CRL Charles River
$234.11 /

-2.205 (-0.93%)

11/03/20 Truist
Charles River price target raised to $256 from $237 at Truist
10/30/20 Deutsche Bank
Charles River price target raised to $250 from $235 at Deutsche Bank
09/14/20 Argus
Charles River price target raised to $235 from $190 at Argus
09/10/20
Fly Intel: Top five analyst upgrades
AXGN AxoGen
$15.16 /

-0.05 (-0.33%)

10/22/20 Guggenheim
AxoGen initiated with a Buy at Guggenheim
06/16/20 Cantor Fitzgerald
AxoGen assumed with an Overweight at Cantor Fitzgerald
06/15/20 Cantor Fitzgerald
AxoGen assumed with an Overweight at Cantor Fitzgerald
05/07/20 Canaccord
AxoGen downgraded to Hold at Canaccord
INMD InMode
$42.75 /

+0.16 (+0.38%)

10/21/20 Canaccord
InMode price target raised to $51 from $42 at Canaccord
10/13/20 Baird
InMode price target raised to $55 from $43 at Baird
02/19/20 Barclays
InMode price target raised to $48 from $45 at Barclays
01/28/20 Baird
InMode price target raised to $55 from $45 at Baird
PRTA Prothena
$12.10 /

-0.24 (-1.94%)

10/21/20 Cantor Fitzgerald
Prothena price target raised to $24 from $20 at Cantor Fitzgerald
07/09/20 Oppenheimer
Prothena upgraded to Outperform at Oppenheimer
07/09/20 Oppenheimer
Prothena upgraded to Outperform from Perform at Oppenheimer
11/19/19 Evercore ISI
Prothena upgraded to Outperform on valuation at Evercore ISI
SYNH Syneos Health
$63.21 /

-0.24 (-0.38%)

10/06/20 Mizuho
Syneos Health upgraded to Buy on attractive entry point at Mizuho
10/06/20 Mizuho
Syneos Health upgraded to Buy from Neutral at Mizuho
10/01/20 Goldman Sachs
Syneos Health upgraded to Buy from Neutral at Goldman Sachs
08/12/20 Truist
Syneos Health price target raised to $80 from $74 at Truist
RDNT RadNet
$18.19 /

-0.75 (-3.96%)

09/03/20 Clarus
Akumin can re-rate as Nasdaq listing raises U.S. awareness, says Clarus
OPNT Opiant Pharmaceuticals
$7.95 /

+0.2 (+2.58%)

FGEN FibroGen
$41.56 /

-2.58 (-5.85%)

10/26/20 Raymond James
FibroGen initiated with an Underperform at Raymond James
10/26/20 Raymond James
FibroGen initiated with an Underperform at Raymond James
10/23/20 Stifel
FibroGen safety data mitigates concerns of roxadustat black box, says Stifel
09/04/20 Stifel
FibroGen's roxadustat can be 'dominant leader' as competitor fades, says Stifel
MGLN Magellan Health
$82.25 /

-2.47 (-2.92%)

11/13/20
Fly Intel: Top five analyst upgrades
11/13/20 Stephens
Magellan Health upgraded to Overweight from Equal Weight at Stephens
RHHBY Roche
$0.00 /

+ (+0.00%)

11/11/20 Truist
Opthea initiated with a Buy at Truist
10/16/20 UBS
Roche price target lowered to CHF 370 from CHF 390 at UBS
10/06/20 Goldman Sachs
Goldman reiterates $34 target on Kiniksa after 'impressive' data
09/29/20 Berenberg
Roche initiated with a Hold at Berenberg
CARA Cara Therapeutics
$15.66 /

-0.53 (-3.27%)

10/20/20 H.C. Wainwright
Cara deal with 'perfect partner' Vifor boosts confidence at H.C. Wainwright
04/22/20 Cantor Fitzgerald
Cara Therapeutics price target raised to $34 from $26 at Cantor Fitzgerald
04/21/20 H.C. Wainwright
Cara Therapeutics price target raised to $33 from $30 at H.C. Wainwright
01/10/20 Stifel
Cara Therapeutics named a BioPharma top pick for 2020 at Stifel
IVA Inventiva
$14.00 /

+ (+0.00%)

10/13/20 Roth Capital
Roth backs Buy on Inventiva after Lanifibranor given breakthrough designation
08/17/20 H.C. Wainwright
Inventiva price target raised to $38 from EUR 12 at H.C. Wainwright
08/05/20
Fly Intel: Top five analyst initiations
08/05/20 Roth Capital
Inventiva initiated with a Buy at Roth Capital
ITOS iTeos Therapeutics
$25.09 /

+1.14 (+4.76%)

10/07/20 Baird
iTeos Therapeutics initiated with an Outperform at Baird
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
09/01/20 Piper Sandler
iTeos Therapeutics heading for 'catalyst rich stretch', says Piper Sandler
08/18/20 SVB Leerink
SVB Leerink bullish on iTeos Therapeutics, initiates with an Outperform
CLBS Caladrius
$1.44 /

-0.055 (-3.68%)

05/22/20 Brookline
Caladrius initiated with a Buy at Brookline
05/18/20 Dawson James
Caladrius downgraded to Neutral from Buy at Dawson James
ALNA Allena Pharmaceuticals
$1.37 /

-0.07 (-4.86%)

10/01/20 B. Riley Securities
Allena Pharmaceuticals price target raised to $5 from $4 at B. Riley Securities
06/01/20 H.C. Wainwright
Allena Pharmaceuticals initiated with a Buy at H.C. Wainwright
03/18/20 Roth Capital
Allena Pharmaceuticals price target lowered to $11 from $31 at Roth Capital
02/12/20 Roth Capital
Streamlining makes Allena URIROX-2 path clear, says Roth Capital
SEEL Seelos Therapeutics
$0.78 /

-0.0296 (-3.65%)

09/09/20 Roth Capital
Seelos Therapeutics shares 'substantially undervalued,' says Roth Capital
06/23/20 Roth Capital
Seelos Therapeutics price target raised to $12 from $8 Roth Capital
SMMNY Siemens Healthineers
$0.00 /

+ (+0.00%)

11/10/20 Credit Suisse
Siemens Healthineers price target raised to EUR 44 from EUR 43 at Credit Suisse
10/28/20 Barrington
Varian Medical downgraded to Underperform from Outperform at Barrington
10/26/20 RBC Capital
Siemens Healthineers price target lowered to EUR 42 from EUR 45 at RBC Capital
10/06/20 Deutsche Bank
Siemens Healthineers price target lowered to EUR 39 at Deutsche Bank
CNCE Concert Pharmaceuticals
$10.82 /

-0.23 (-2.08%)

11/04/20 JMP Securities
Concert Pharmaceuticals resumed with an Outperform at JMP Securities
03/30/20
Fly Intel: Top five analyst initiations
03/30/20 Jefferies
Concert Pharmaceuticals initiated with a Buy at Jefferies
02/27/20 Stifel
Concert Pharmaceuticals price target raised to $11 from $8 at Stifel
SYNH Syneos Health
$63.21 /

-0.24 (-0.38%)

RHHBY Roche
$0.00 /

+ (+0.00%)

RDNT RadNet
$18.19 /

-0.75 (-3.96%)

PRTA Prothena
$12.10 /

-0.24 (-1.94%)

OPNT Opiant Pharmaceuticals
$7.95 /

+0.2 (+2.58%)

MRNA Moderna
$88.90 /

-4.225 (-4.54%)

MGLN Magellan Health
$82.25 /

-2.47 (-2.92%)

ITOS iTeos Therapeutics
$25.09 /

+1.14 (+4.76%)

INMD InMode
$42.75 /

+0.16 (+0.38%)

IMGN ImmunoGen
$5.75 /

-0.035 (-0.61%)

FGEN FibroGen
$41.56 /

-2.58 (-5.85%)

ESPR Esperion
$29.18 /

-0.95 (-3.15%)

CRL Charles River
$234.11 /

-2.205 (-0.93%)

CNCE Concert Pharmaceuticals
$10.82 /

-0.23 (-2.08%)

CLBS Caladrius
$1.44 /

-0.055 (-3.68%)

CARA Cara Therapeutics
$15.66 /

-0.53 (-3.27%)

AXGN AxoGen
$15.16 /

-0.05 (-0.33%)

ALNA Allena Pharmaceuticals
$1.37 /

-0.07 (-4.86%)

  • 16
    Sep
  • 24
    Jul
  • 10
    Jul
  • 19
    May
  • 12
    Mar
  • 11
    Feb
  • 12
    Feb
  • 28
    Jan
  • 21
    Jan
RHHBY Roche
$0.00 /

+ (+0.00%)

MRNA Moderna
$88.90 /

-4.225 (-4.54%)

SYNH Syneos Health
$63.21 /

-0.24 (-0.38%)

SMMNY Siemens Healthineers
$0.00 /

+ (+0.00%)

RHHBY Roche
$0.00 /

+ (+0.00%)

MRNA Moderna
$88.90 /

-4.225 (-4.54%)

IVA Inventiva
$14.00 /

+ (+0.00%)

ITOS iTeos Therapeutics
$25.09 /

+1.14 (+4.76%)

IMGN ImmunoGen
$5.75 /

-0.035 (-0.61%)

FGEN FibroGen
$41.56 /

-2.58 (-5.85%)

ESPR Esperion
$29.18 /

-0.95 (-3.15%)

CARA Cara Therapeutics
$15.66 /

-0.53 (-3.27%)

AXGN AxoGen
$15.16 /

-0.05 (-0.33%)

MRNA Moderna
$88.90 /

-4.225 (-4.54%)

FGEN FibroGen
$41.56 /

-2.58 (-5.85%)

ESPR Esperion
$29.18 /

-0.95 (-3.15%)

Conference/Events
Jefferies to hold a virtual conference » 04:55
11/18/20
11/18
04:55
11/18/20
04:55
MRNA

Moderna

$93.12 /

-4.88 (-4.98%)

, IMGN

ImmunoGen

$5.78 /

+0.03 (+0.52%)

, ESPR

Esperion

$30.13 /

+0.02 (+0.07%)

, CRL

Charles River

$236.30 /

-1.56 (-0.66%)

, AXGN

AxoGen

$15.29 /

+0.18 (+1.19%)

, INMD

InMode

$42.61 /

+0.8 (+1.91%)

, PRTA

Prothena

$12.34 /

-0.03 (-0.24%)

, SYNH

Syneos Health

$63.45 /

-0.37 (-0.58%)

, RDNT

RadNet

$18.94 /

-0.05 (-0.26%)

, OPNT

Opiant Pharmaceuticals

$7.78 /

-0.02 (-0.26%)

, FGEN

FibroGen

$44.14 /

+1.12 (+2.60%)

, MGLN

Magellan Health

$84.72 /

-0.64 (-0.75%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

, CARA

Cara Therapeutics

$16.19 /

+0.5 (+3.19%)

, IVA

Inventiva

$14.00 /

+0.175 (+1.27%)

, ITOS

iTeos Therapeutics

$23.95 /

-0.08 (-0.33%)

, CLBS

Caladrius

$1.50 /

-0.005 (-0.33%)

, ALNA

Allena Pharmaceuticals

$1.43 /

-0.15 (-9.49%)

, SEEL

Seelos Therapeutics

$0.81 /

-0.0119 (-1.45%)

, SMMNY

Siemens Healthineers

$0.00 /

+ (+0.00%)

, CNCE

Concert Pharmaceuticals

$11.04 /

+0.03 (+0.27%)

Virtual Healthcare…

Virtual Healthcare Conference will be held on November 17-19.

ShowHide Related Items >><<
SYNH Syneos Health
$63.45 /

-0.37 (-0.58%)

SMMNY Siemens Healthineers
$0.00 /

+ (+0.00%)

SEEL Seelos Therapeutics
$0.81 /

-0.0119 (-1.45%)

RHHBY Roche
$0.00 /

+ (+0.00%)

RDNT RadNet
$18.94 /

-0.05 (-0.26%)

PRTA Prothena
$12.34 /

-0.03 (-0.24%)

OPNT Opiant Pharmaceuticals
$7.78 /

-0.02 (-0.26%)

MRNA Moderna
$93.12 /

-4.88 (-4.98%)

MGLN Magellan Health
$84.72 /

-0.64 (-0.75%)

IVA Inventiva
$14.00 /

+0.175 (+1.27%)

ITOS iTeos Therapeutics
$23.95 /

-0.08 (-0.33%)

INMD InMode
$42.61 /

+0.8 (+1.91%)

IMGN ImmunoGen
$5.78 /

+0.03 (+0.52%)

FGEN FibroGen
$44.14 /

+1.12 (+2.60%)

ESPR Esperion
$30.13 /

+0.02 (+0.07%)

CRL Charles River
$236.30 /

-1.56 (-0.66%)

CNCE Concert Pharmaceuticals
$11.04 /

+0.03 (+0.27%)

CLBS Caladrius
$1.50 /

-0.005 (-0.33%)

CARA Cara Therapeutics
$16.19 /

+0.5 (+3.19%)

AXGN AxoGen
$15.29 /

+0.18 (+1.19%)

ALNA Allena Pharmaceuticals
$1.43 /

-0.15 (-9.49%)

MRNA Moderna
$93.12 /

-4.88 (-4.98%)

11/17/20 Benchmark
Inovio on 'top-10 vaccine contenders list,' says Benchmark
11/17/20 Maxim
Co-Diagnostics price target lowered to $20 from $30 at Maxim
11/17/20 Roth Capital
Inovio downgraded to Sell at Roth Capital on increased competition
11/17/20 Redburn
Moderna initiated with a Sell at Redburn
IMGN ImmunoGen
$5.78 /

+0.03 (+0.52%)

10/26/20 H.C. Wainwright
ImmunoGen assumed with a Buy at H.C. Wainwright
10/19/20 Piper Sandler
Greater China partnership 'very favorable' for ImmunoGen, says Piper Sandler
10/05/20 Piper Sandler
Piper says r/r BPDCN revenue opportunity for ImmunoGen's 632 'an open question'
10/02/20 Guggenheim
ImmunoGen upgraded to Buy from Neutral at Guggenheim
ESPR Esperion
$30.13 /

+0.02 (+0.07%)

11/10/20 Credit Suisse
Esperion upgraded to Outperform from Neutral at Credit Suisse
09/29/20 JPMorgan
Esperion resumed with an Underweight at JPMorgan
08/10/20 Credit Suisse
Esperion downgraded to Neutral from Outperform at Credit Suisse
05/07/20 Citi
Esperion price target raised to $56 from $46 at Citi
CRL Charles River
$236.30 /

-1.56 (-0.66%)

11/03/20 Truist
Charles River price target raised to $256 from $237 at Truist
10/30/20 Deutsche Bank
Charles River price target raised to $250 from $235 at Deutsche Bank
09/14/20 Argus
Charles River price target raised to $235 from $190 at Argus
09/10/20
Fly Intel: Top five analyst upgrades
AXGN AxoGen
$15.29 /

+0.18 (+1.19%)

10/22/20 Guggenheim
AxoGen initiated with a Buy at Guggenheim
06/16/20 Cantor Fitzgerald
AxoGen assumed with an Overweight at Cantor Fitzgerald
06/15/20 Cantor Fitzgerald
AxoGen assumed with an Overweight at Cantor Fitzgerald
05/07/20 Canaccord
AxoGen downgraded to Hold at Canaccord
INMD InMode
$42.61 /

+0.8 (+1.91%)

10/21/20 Canaccord
InMode price target raised to $51 from $42 at Canaccord
10/13/20 Baird
InMode price target raised to $55 from $43 at Baird
02/19/20 Barclays
InMode price target raised to $48 from $45 at Barclays
01/28/20 Baird
InMode price target raised to $55 from $45 at Baird
PRTA Prothena
$12.34 /

-0.03 (-0.24%)

10/21/20 Cantor Fitzgerald
Prothena price target raised to $24 from $20 at Cantor Fitzgerald
07/09/20 Oppenheimer
Prothena upgraded to Outperform at Oppenheimer
07/09/20 Oppenheimer
Prothena upgraded to Outperform from Perform at Oppenheimer
11/19/19 Evercore ISI
Prothena upgraded to Outperform on valuation at Evercore ISI
SYNH Syneos Health
$63.45 /

-0.37 (-0.58%)

10/06/20 Mizuho
Syneos Health upgraded to Buy on attractive entry point at Mizuho
10/06/20 Mizuho
Syneos Health upgraded to Buy from Neutral at Mizuho
10/01/20 Goldman Sachs
Syneos Health upgraded to Buy from Neutral at Goldman Sachs
08/12/20 Truist
Syneos Health price target raised to $80 from $74 at Truist
RDNT RadNet
$18.94 /

-0.05 (-0.26%)

09/03/20 Clarus
Akumin can re-rate as Nasdaq listing raises U.S. awareness, says Clarus
OPNT Opiant Pharmaceuticals
$7.78 /

-0.02 (-0.26%)

FGEN FibroGen
$44.14 /

+1.12 (+2.60%)

10/26/20 Raymond James
FibroGen initiated with an Underperform at Raymond James
10/26/20 Raymond James
FibroGen initiated with an Underperform at Raymond James
10/23/20 Stifel
FibroGen safety data mitigates concerns of roxadustat black box, says Stifel
09/04/20 Stifel
FibroGen's roxadustat can be 'dominant leader' as competitor fades, says Stifel
MGLN Magellan Health
$84.72 /

-0.64 (-0.75%)

11/13/20
Fly Intel: Top five analyst upgrades
11/13/20 Stephens
Magellan Health upgraded to Overweight from Equal Weight at Stephens
RHHBY Roche
$0.00 /

+ (+0.00%)

11/11/20 Truist
Opthea initiated with a Buy at Truist
10/16/20 UBS
Roche price target lowered to CHF 370 from CHF 390 at UBS
10/06/20 Goldman Sachs
Goldman reiterates $34 target on Kiniksa after 'impressive' data
09/29/20 Berenberg
Roche initiated with a Hold at Berenberg
CARA Cara Therapeutics
$16.19 /

+0.5 (+3.19%)

10/20/20 H.C. Wainwright
Cara deal with 'perfect partner' Vifor boosts confidence at H.C. Wainwright
04/22/20 Cantor Fitzgerald
Cara Therapeutics price target raised to $34 from $26 at Cantor Fitzgerald
04/21/20 H.C. Wainwright
Cara Therapeutics price target raised to $33 from $30 at H.C. Wainwright
01/10/20 Stifel
Cara Therapeutics named a BioPharma top pick for 2020 at Stifel
IVA Inventiva
$14.00 /

+0.175 (+1.27%)

10/13/20 Roth Capital
Roth backs Buy on Inventiva after Lanifibranor given breakthrough designation
08/17/20 H.C. Wainwright
Inventiva price target raised to $38 from EUR 12 at H.C. Wainwright
08/05/20
Fly Intel: Top five analyst initiations
08/05/20 Roth Capital
Inventiva initiated with a Buy at Roth Capital
ITOS iTeos Therapeutics
$23.95 /

-0.08 (-0.33%)

10/07/20 Baird
iTeos Therapeutics initiated with an Outperform at Baird
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
09/01/20 Piper Sandler
iTeos Therapeutics heading for 'catalyst rich stretch', says Piper Sandler
08/18/20 SVB Leerink
SVB Leerink bullish on iTeos Therapeutics, initiates with an Outperform
CLBS Caladrius
$1.50 /

-0.005 (-0.33%)

05/22/20 Brookline
Caladrius initiated with a Buy at Brookline
05/18/20 Dawson James
Caladrius downgraded to Neutral from Buy at Dawson James
ALNA Allena Pharmaceuticals
$1.43 /

-0.15 (-9.49%)

10/01/20 B. Riley Securities
Allena Pharmaceuticals price target raised to $5 from $4 at B. Riley Securities
06/01/20 H.C. Wainwright
Allena Pharmaceuticals initiated with a Buy at H.C. Wainwright
03/18/20 Roth Capital
Allena Pharmaceuticals price target lowered to $11 from $31 at Roth Capital
02/12/20 Roth Capital
Streamlining makes Allena URIROX-2 path clear, says Roth Capital
SEEL Seelos Therapeutics
$0.81 /

-0.0119 (-1.45%)

09/09/20 Roth Capital
Seelos Therapeutics shares 'substantially undervalued,' says Roth Capital
06/23/20 Roth Capital
Seelos Therapeutics price target raised to $12 from $8 Roth Capital
11/18/19 H.C. Wainwright
Seelos Therapeutics price target lowered to $2 from $4 at H.C. Wainwright
SMMNY Siemens Healthineers
$0.00 /

+ (+0.00%)

11/10/20 Credit Suisse
Siemens Healthineers price target raised to EUR 44 from EUR 43 at Credit Suisse
10/28/20 Barrington
Varian Medical downgraded to Underperform from Outperform at Barrington
10/26/20 RBC Capital
Siemens Healthineers price target lowered to EUR 42 from EUR 45 at RBC Capital
10/06/20 Deutsche Bank
Siemens Healthineers price target lowered to EUR 39 at Deutsche Bank
CNCE Concert Pharmaceuticals
$11.04 /

+0.03 (+0.27%)

11/04/20 JMP Securities
Concert Pharmaceuticals resumed with an Outperform at JMP Securities
03/30/20
Fly Intel: Top five analyst initiations
03/30/20 Jefferies
Concert Pharmaceuticals initiated with a Buy at Jefferies
02/27/20 Stifel
Concert Pharmaceuticals price target raised to $11 from $8 at Stifel
SYNH Syneos Health
$63.45 /

-0.37 (-0.58%)

RHHBY Roche
$0.00 /

+ (+0.00%)

RDNT RadNet
$18.94 /

-0.05 (-0.26%)

PRTA Prothena
$12.34 /

-0.03 (-0.24%)

OPNT Opiant Pharmaceuticals
$7.78 /

-0.02 (-0.26%)

MRNA Moderna
$93.12 /

-4.88 (-4.98%)

MGLN Magellan Health
$84.72 /

-0.64 (-0.75%)

ITOS iTeos Therapeutics
$23.95 /

-0.08 (-0.33%)

INMD InMode
$42.61 /

+0.8 (+1.91%)

IMGN ImmunoGen
$5.78 /

+0.03 (+0.52%)

FGEN FibroGen
$44.14 /

+1.12 (+2.60%)

ESPR Esperion
$30.13 /

+0.02 (+0.07%)

CRL Charles River
$236.30 /

-1.56 (-0.66%)

CNCE Concert Pharmaceuticals
$11.04 /

+0.03 (+0.27%)

CLBS Caladrius
$1.50 /

-0.005 (-0.33%)

CARA Cara Therapeutics
$16.19 /

+0.5 (+3.19%)

AXGN AxoGen
$15.29 /

+0.18 (+1.19%)

ALNA Allena Pharmaceuticals
$1.43 /

-0.15 (-9.49%)

  • 16
    Sep
  • 24
    Jul
  • 10
    Jul
  • 19
    May
  • 12
    Mar
  • 11
    Feb
  • 12
    Feb
  • 28
    Jan
  • 21
    Jan
RHHBY Roche
$0.00 /

+ (+0.00%)

MRNA Moderna
$93.12 /

-4.88 (-4.98%)

SYNH Syneos Health
$63.45 /

-0.37 (-0.58%)

SMMNY Siemens Healthineers
$0.00 /

+ (+0.00%)

RHHBY Roche
$0.00 /

+ (+0.00%)

MRNA Moderna
$93.12 /

-4.88 (-4.98%)

IVA Inventiva
$14.00 /

+0.175 (+1.27%)

ITOS iTeos Therapeutics
$23.95 /

-0.08 (-0.33%)

IMGN ImmunoGen
$5.78 /

+0.03 (+0.52%)

FGEN FibroGen
$44.14 /

+1.12 (+2.60%)

ESPR Esperion
$30.13 /

+0.02 (+0.07%)

CARA Cara Therapeutics
$16.19 /

+0.5 (+3.19%)

AXGN AxoGen
$15.29 /

+0.18 (+1.19%)

MRNA Moderna
$93.12 /

-4.88 (-4.98%)

FGEN FibroGen
$44.14 /

+1.12 (+2.60%)

ESPR Esperion
$30.13 /

+0.02 (+0.07%)

Conference/Events
Stifel to hold a virtual conference » 04:55
11/18/20
11/18
04:55
11/18/20
04:55
SAGE

Sage Therapeutics

$74.20 /

+0.8 (+1.09%)

, EXAS

Exact Sciences

$115.69 /

-5.6 (-4.62%)

, QURE

uniQure

$44.33 /

+0.4 (+0.91%)

, LMAT

LeMaitre

$38.79 /

+0.6 (+1.57%)

, TRXC

TransEnterix

$0.42 /

-0.0045 (-1.07%)

, PRTA

Prothena

$12.34 /

-0.03 (-0.24%)

, IRIX

Iridex

$1.72 /

+0.015 (+0.88%)

, CARA

Cara Therapeutics

$16.19 /

+0.5 (+3.19%)

, CNCE

Concert Pharmaceuticals

$11.04 /

+0.03 (+0.27%)

, IVA

Inventiva

$14.00 /

+0.175 (+1.27%)

, NRIX

Nurix Therapeutics

$33.08 /

+1.05 (+3.28%)

, SPRO

Spero Therapeutics

$14.71 /

-0.05 (-0.34%)

, OM

Outset Medical

$60.92 /

+0.35 (+0.58%)

, AVNS

Avanos

$42.91 /

+0.46 (+1.08%)

, KIDS

OrthoPediatrics

$46.39 /

-0.63 (-1.34%)

, ZBH

Zimmer Biomet

$150.20 /

-0.1 (-0.07%)

, CBIO

Catalyst Biosciences

$5.79 /

-0.18 (-3.02%)

, FGEN

FibroGen

$44.14 /

+1.12 (+2.60%)

, PKI

PerkinElmer

$133.00 /

-0.35 (-0.26%)

Virtual Healthcare…

Virtual Healthcare Conference 2020 will be held on November 16-18.

ShowHide Related Items >><<
ZBH Zimmer Biomet
$150.20 /

-0.1 (-0.07%)

TRXC TransEnterix
$0.42 /

-0.0045 (-1.07%)

SPRO Spero Therapeutics
$14.71 /

-0.05 (-0.34%)

SAGE Sage Therapeutics
$74.20 /

+0.8 (+1.09%)

QURE uniQure
$44.33 /

+0.4 (+0.91%)

PRTA Prothena
$12.34 /

-0.03 (-0.24%)

PKI PerkinElmer
$133.00 /

-0.35 (-0.26%)

OM Outset Medical
$60.92 /

+0.35 (+0.58%)

NRIX Nurix Therapeutics
$33.08 /

+1.05 (+3.28%)

LMAT LeMaitre
$38.79 /

+0.6 (+1.57%)

KIDS OrthoPediatrics
$46.39 /

-0.63 (-1.34%)

IVA Inventiva
$14.00 /

+0.175 (+1.27%)

FGEN FibroGen
$44.14 /

+1.12 (+2.60%)

EXAS Exact Sciences
$115.69 /

-5.6 (-4.62%)

CNCE Concert Pharmaceuticals
$11.04 /

+0.03 (+0.27%)

CBIO Catalyst Biosciences
$5.79 /

-0.18 (-3.02%)

CARA Cara Therapeutics
$16.19 /

+0.5 (+3.19%)

AVNS Avanos
$42.91 /

+0.46 (+1.08%)

SAGE Sage Therapeutics
$74.20 /

+0.8 (+1.09%)

11/16/20
Fly Intel: Top five analyst downgrades
11/16/20 Morgan Stanley
Morgan Stanley downgrades Sage Therapeutics amid 'reasonable' expectations
11/16/20 Morgan Stanley
Sage Therapeutics downgraded to Equal Weight from Overweight at Morgan Stanley
11/11/20 Wedbush
Wedbush bullish on Praxis Precision Medicines, initiates with an Outperform
EXAS Exact Sciences
$115.69 /

-5.6 (-4.62%)

10/29/20
Fly Intel: Top five analyst downgrades
10/29/20 UBS
Exact Sciences downgraded to Neutral from Buy at UBS
10/28/20
Fly Intel: Top five analyst downgrades
10/28/20 Benchmark
Exact Sciences price target raised to $145 from $110 at Benchmark
QURE uniQure
$44.33 /

+0.4 (+0.91%)

11/11/20 Berenberg
Biotechnology companies initiated at Berenberg
11/11/20 Berenberg
uniQure initiated with a Buy at Berenberg
11/09/20 Jefferies
uniQure initiated with a Buy at Jefferies
11/04/20
Fly Intel: Top five analyst initiations
LMAT LeMaitre
$38.79 /

+0.6 (+1.57%)

10/30/20 Barrington
LeMaitre price target raised to $46 from $36 at Barrington
10/28/20 Barrington
Varian Medical downgraded to Underperform from Outperform at Barrington
07/24/20 Lake Street
LeMaitre price target raised to $38 from $33 at Lake Street
05/04/20 Roth Capital
LeMaitre price target lowered to $28 from $32.50 at Roth Capital
TRXC TransEnterix
$0.42 /

-0.0045 (-1.07%)

PRTA Prothena
$12.34 /

-0.03 (-0.24%)

10/21/20 Cantor Fitzgerald
Prothena price target raised to $24 from $20 at Cantor Fitzgerald
07/09/20 Oppenheimer
Prothena upgraded to Outperform at Oppenheimer
07/09/20 Oppenheimer
Prothena upgraded to Outperform from Perform at Oppenheimer
11/19/19 Evercore ISI
Prothena upgraded to Outperform on valuation at Evercore ISI
IRIX Iridex
$1.72 /

+0.015 (+0.88%)

CARA Cara Therapeutics
$16.19 /

+0.5 (+3.19%)

10/20/20 H.C. Wainwright
Cara deal with 'perfect partner' Vifor boosts confidence at H.C. Wainwright
04/22/20 Cantor Fitzgerald
Cara Therapeutics price target raised to $34 from $26 at Cantor Fitzgerald
04/21/20 H.C. Wainwright
Cara Therapeutics price target raised to $33 from $30 at H.C. Wainwright
01/10/20 Stifel
Cara Therapeutics named a BioPharma top pick for 2020 at Stifel
CNCE Concert Pharmaceuticals
$11.04 /

+0.03 (+0.27%)

11/04/20 JMP Securities
Concert Pharmaceuticals resumed with an Outperform at JMP Securities
03/30/20
Fly Intel: Top five analyst initiations
03/30/20 Jefferies
Concert Pharmaceuticals initiated with a Buy at Jefferies
02/27/20 Stifel
Concert Pharmaceuticals price target raised to $11 from $8 at Stifel
IVA Inventiva
$14.00 /

+0.175 (+1.27%)

10/13/20 Roth Capital
Roth backs Buy on Inventiva after Lanifibranor given breakthrough designation
08/17/20 H.C. Wainwright
Inventiva price target raised to $38 from EUR 12 at H.C. Wainwright
08/05/20
Fly Intel: Top five analyst initiations
08/05/20 Roth Capital
Inventiva initiated with a Buy at Roth Capital
NRIX Nurix Therapeutics
$33.08 /

+1.05 (+3.28%)

08/18/20
Fly Intel: Top five analyst initiations
08/18/20 JPMorgan
Nurix Therapeutics initiated with an Overweight at JPMorgan
08/18/20 Needham
Nurix Therapeutics initiated with a Buy at Needham
08/18/20 Stifel
Nurix Therapeutics initiated with a Buy at Stifel
SPRO Spero Therapeutics
$14.71 /

-0.05 (-0.34%)

09/29/20 Evercore ISI
Spero Therapeutics initiated with an Outperform at Evercore ISI
09/08/20 Stifel
Spero Therapeutics price target raised to $25 from $21 at Stifel
05/11/20 H.C. Wainwright
Spero Therapeutics price target raised to $28 from $25 at H.C. Wainwright
OM Outset Medical
$60.92 /

+0.35 (+0.58%)

10/12/20
Fly Intel: Top five analyst initiations
10/12/20 Morgan Stanley
Outset Medical initiated with an Equal Weight at Morgan Stanley
10/12/20 Stifel
Outset Medical initiated with a Buy at Stifel
10/12/20 SVB Leerink
Outset Medical initiated with a Market Perform at SVB Leerink
AVNS Avanos
$42.91 /

+0.46 (+1.08%)

04/13/20 Barclays
Avanos upgraded to Equal Weight from Underweight at Barclays
12/30/19 Stifel
Avanos makes 'welcome addition' with 'highly experienced' CFO, says Stifel
KIDS OrthoPediatrics
$46.39 /

-0.63 (-1.34%)

10/07/20 BTIG
OrthoPediatrics price target raised to $57 from $54 at BTIG
08/06/20 Piper Sandler
Piper says OrthoPediatrics can win in 'more muted competitive environment'
08/06/20 Needham
OrthoPediatrics price target raised to $57 from $49 at Needham
06/23/20 Piper Sandler
OrthoPediatrics recovery better than expected, says Piper Sandler
ZBH Zimmer Biomet
$150.20 /

-0.1 (-0.07%)

11/09/20 SVB Leerink
Zimmer Biomet price target raised to $167 from $160 at SVB Leerink
11/09/20 Credit Suisse
Zimmer Biomet price target raised to $106 from $99 at Credit Suisse
11/09/20 Baird
Zimmer Biomet valuation discount to peers hard to justify, says at Baird
11/09/20 Oppenheimer
Zimmer Biomet price target raised to $155 from $150 at Oppenheimer
CBIO Catalyst Biosciences
$5.79 /

-0.18 (-3.02%)

05/21/20 Raymond James
Catalyst Biosciences initiated with an Outperform at Raymond James
FGEN FibroGen
$44.14 /

+1.12 (+2.60%)

10/26/20 Raymond James
FibroGen initiated with an Underperform at Raymond James
10/26/20 Raymond James
FibroGen initiated with an Underperform at Raymond James
10/23/20 Stifel
FibroGen safety data mitigates concerns of roxadustat black box, says Stifel
09/04/20 Stifel
FibroGen's roxadustat can be 'dominant leader' as competitor fades, says Stifel
PKI PerkinElmer
$133.00 /

-0.35 (-0.26%)

11/09/20 KeyBanc
PerkinElmer initiated with a Sector Weight at KeyBanc
11/09/20 Needham
PerkinElmer price target raised to $193 from $139 at Needham
10/29/20 Wells Fargo
PerkinElmer price target raised to $140 from $130 at Wells Fargo
10/29/20 Baird
PerkinElmer price target raised to $151 from $137 at Baird
ZBH Zimmer Biomet
$150.20 /

-0.1 (-0.07%)

SPRO Spero Therapeutics
$14.71 /

-0.05 (-0.34%)

SAGE Sage Therapeutics
$74.20 /

+0.8 (+1.09%)

QURE uniQure
$44.33 /

+0.4 (+0.91%)

PRTA Prothena
$12.34 /

-0.03 (-0.24%)

PKI PerkinElmer
$133.00 /

-0.35 (-0.26%)

OM Outset Medical
$60.92 /

+0.35 (+0.58%)

NRIX Nurix Therapeutics
$33.08 /

+1.05 (+3.28%)

LMAT LeMaitre
$38.79 /

+0.6 (+1.57%)

KIDS OrthoPediatrics
$46.39 /

-0.63 (-1.34%)

IRIX Iridex
$1.72 /

+0.015 (+0.88%)

FGEN FibroGen
$44.14 /

+1.12 (+2.60%)

EXAS Exact Sciences
$115.69 /

-5.6 (-4.62%)

CNCE Concert Pharmaceuticals
$11.04 /

+0.03 (+0.27%)

CBIO Catalyst Biosciences
$5.79 /

-0.18 (-3.02%)

CARA Cara Therapeutics
$16.19 /

+0.5 (+3.19%)

AVNS Avanos
$42.91 /

+0.46 (+1.08%)

  • 11
    Sep
  • 15
    Sep
  • 24
    Jul
  • 10
    Jul
  • 18
    Jun
  • 18
    Jun
  • 13
    Feb
  • 28
    Jan
  • 11
    Dec
QURE uniQure
$44.33 /

+0.4 (+0.91%)

PKI PerkinElmer
$133.00 /

-0.35 (-0.26%)

SPRO Spero Therapeutics
$14.71 /

-0.05 (-0.34%)

QURE uniQure
$44.33 /

+0.4 (+0.91%)

PKI PerkinElmer
$133.00 /

-0.35 (-0.26%)

OM Outset Medical
$60.92 /

+0.35 (+0.58%)

NRIX Nurix Therapeutics
$33.08 /

+1.05 (+3.28%)

LMAT LeMaitre
$38.79 /

+0.6 (+1.57%)

KIDS OrthoPediatrics
$46.39 /

-0.63 (-1.34%)

IVA Inventiva
$14.00 /

+0.175 (+1.27%)

FGEN FibroGen
$44.14 /

+1.12 (+2.60%)

EXAS Exact Sciences
$115.69 /

-5.6 (-4.62%)

CBIO Catalyst Biosciences
$5.79 /

-0.18 (-3.02%)

CARA Cara Therapeutics
$16.19 /

+0.5 (+3.19%)

TRXC TransEnterix
$0.42 /

-0.0045 (-1.07%)

PKI PerkinElmer
$133.00 /

-0.35 (-0.26%)

FGEN FibroGen
$44.14 /

+1.12 (+2.60%)

EXAS Exact Sciences
$115.69 /

-5.6 (-4.62%)

Conference/Events
Jefferies to hold a virtual conference » 08:54
11/17/20
11/17
08:54
11/17/20
08:54
MRNA

Moderna

$97.95 /

+8.65 (+9.69%)

, IMGN

ImmunoGen

$5.75 /

-0.1 (-1.71%)

, ESPR

Esperion

$30.11 /

+1.45 (+5.06%)

, CRL

Charles River

$237.94 /

-0.75 (-0.31%)

, AXGN

AxoGen

$15.09 /

+0.445 (+3.04%)

, INMD

InMode

$41.88 /

-0.01 (-0.02%)

, PRTA

Prothena

$12.37 /

+0.07 (+0.57%)

, SYNH

Syneos Health

$63.82 /

+0.48 (+0.76%)

, RDNT

RadNet

$18.99 /

+0.43 (+2.32%)

, OPNT

Opiant Pharmaceuticals

$7.83 /

+0.045 (+0.58%)

, FGEN

FibroGen

$43.03 /

+0.79 (+1.87%)

, MGLN

Magellan Health

$85.23 /

+0.11 (+0.13%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

, CARA

Cara Therapeutics

$15.69 /

+0.28 (+1.82%)

, IVA

Inventiva

$14.00 /

-0.005 (-0.04%)

, ITOS

iTeos Therapeutics

$24.03 /

+0.36 (+1.52%)

, CLBS

Caladrius

$1.50 /

-0.01 (-0.66%)

, ALNA

Allena Pharmaceuticals

$1.58 /

+0.07 (+4.64%)

, SEEL

Seelos Therapeutics

$0.82 /

-0.0299 (-3.52%)

, SMMNY

Siemens Healthineers

$0.00 /

+ (+0.00%)

, CNCE

Concert Pharmaceuticals

$11.01 /

-0.05 (-0.45%)

Virtual Healthcare…

Virtual Healthcare Conference will be held on November 17-19.

ShowHide Related Items >><<
SYNH Syneos Health
$63.82 /

+0.48 (+0.76%)

SMMNY Siemens Healthineers
$0.00 /

+ (+0.00%)

SEEL Seelos Therapeutics
$0.82 /

-0.0299 (-3.52%)

RHHBY Roche
$0.00 /

+ (+0.00%)

RDNT RadNet
$18.99 /

+0.43 (+2.32%)

PRTA Prothena
$12.37 /

+0.07 (+0.57%)

OPNT Opiant Pharmaceuticals
$7.83 /

+0.045 (+0.58%)

MRNA Moderna
$97.95 /

+8.65 (+9.69%)

MGLN Magellan Health
$85.23 /

+0.11 (+0.13%)

IVA Inventiva
$14.00 /

-0.005 (-0.04%)

ITOS iTeos Therapeutics
$24.03 /

+0.36 (+1.52%)

INMD InMode
$41.88 /

-0.01 (-0.02%)

IMGN ImmunoGen
$5.75 /

-0.1 (-1.71%)

FGEN FibroGen
$43.03 /

+0.79 (+1.87%)

ESPR Esperion
$30.11 /

+1.45 (+5.06%)

CRL Charles River
$237.94 /

-0.75 (-0.31%)

CNCE Concert Pharmaceuticals
$11.01 /

-0.05 (-0.45%)

CLBS Caladrius
$1.50 /

-0.01 (-0.66%)

CARA Cara Therapeutics
$15.69 /

+0.28 (+1.82%)

AXGN AxoGen
$15.09 /

+0.445 (+3.04%)

ALNA Allena Pharmaceuticals
$1.58 /

+0.07 (+4.64%)

MRNA Moderna
$97.95 /

+8.65 (+9.69%)

11/17/20 Maxim
Co-Diagnostics price target lowered to $20 from $30 at Maxim
11/17/20 Roth Capital
Inovio downgraded to Sell at Roth Capital on increased competition
11/17/20 Redburn
Moderna initiated with a Sell at Redburn
11/17/20 BMO Capital
Moderna downgraded to Market Perform from Outperform at BMO Capital
IMGN ImmunoGen
$5.75 /

-0.1 (-1.71%)

10/26/20 H.C. Wainwright
ImmunoGen assumed with a Buy at H.C. Wainwright
10/19/20 Piper Sandler
Greater China partnership 'very favorable' for ImmunoGen, says Piper Sandler
10/05/20 Piper Sandler
Piper says r/r BPDCN revenue opportunity for ImmunoGen's 632 'an open question'
10/02/20 Guggenheim
ImmunoGen upgraded to Buy from Neutral at Guggenheim
ESPR Esperion
$30.11 /

+1.45 (+5.06%)

11/10/20 Credit Suisse
Esperion upgraded to Outperform from Neutral at Credit Suisse
09/29/20 JPMorgan
Esperion resumed with an Underweight at JPMorgan
08/10/20 Credit Suisse
Esperion downgraded to Neutral from Outperform at Credit Suisse
05/07/20 Citi
Esperion price target raised to $56 from $46 at Citi
CRL Charles River
$237.94 /

-0.75 (-0.31%)

11/03/20 Truist
Charles River price target raised to $256 from $237 at Truist
10/30/20 Deutsche Bank
Charles River price target raised to $250 from $235 at Deutsche Bank
09/14/20 Argus
Charles River price target raised to $235 from $190 at Argus
09/10/20
Fly Intel: Top five analyst upgrades
AXGN AxoGen
$15.09 /

+0.445 (+3.04%)

10/22/20 Guggenheim
AxoGen initiated with a Buy at Guggenheim
06/16/20 Cantor Fitzgerald
AxoGen assumed with an Overweight at Cantor Fitzgerald
06/15/20 Cantor Fitzgerald
AxoGen assumed with an Overweight at Cantor Fitzgerald
05/07/20 Canaccord
AxoGen downgraded to Hold at Canaccord
INMD InMode
$41.88 /

-0.01 (-0.02%)

10/21/20 Canaccord
InMode price target raised to $51 from $42 at Canaccord
10/13/20 Baird
InMode price target raised to $55 from $43 at Baird
02/19/20 Barclays
InMode price target raised to $48 from $45 at Barclays
01/28/20 Baird
InMode price target raised to $55 from $45 at Baird
PRTA Prothena
$12.37 /

+0.07 (+0.57%)

10/21/20 Cantor Fitzgerald
Prothena price target raised to $24 from $20 at Cantor Fitzgerald
07/09/20 Oppenheimer
Prothena upgraded to Outperform at Oppenheimer
07/09/20 Oppenheimer
Prothena upgraded to Outperform from Perform at Oppenheimer
11/19/19 Evercore ISI
Prothena upgraded to Outperform on valuation at Evercore ISI
SYNH Syneos Health
$63.82 /

+0.48 (+0.76%)

10/06/20 Mizuho
Syneos Health upgraded to Buy on attractive entry point at Mizuho
10/06/20 Mizuho
Syneos Health upgraded to Buy from Neutral at Mizuho
10/01/20 Goldman Sachs
Syneos Health upgraded to Buy from Neutral at Goldman Sachs
08/12/20 Truist
Syneos Health price target raised to $80 from $74 at Truist
RDNT RadNet
$18.99 /

+0.43 (+2.32%)

09/03/20 Clarus
Akumin can re-rate as Nasdaq listing raises U.S. awareness, says Clarus
OPNT Opiant Pharmaceuticals
$7.83 /

+0.045 (+0.58%)

FGEN FibroGen
$43.03 /

+0.79 (+1.87%)

10/26/20 Raymond James
FibroGen initiated with an Underperform at Raymond James
10/26/20 Raymond James
FibroGen initiated with an Underperform at Raymond James
10/23/20 Stifel
FibroGen safety data mitigates concerns of roxadustat black box, says Stifel
09/04/20 Stifel
FibroGen's roxadustat can be 'dominant leader' as competitor fades, says Stifel
MGLN Magellan Health
$85.23 /

+0.11 (+0.13%)

11/13/20
Fly Intel: Top five analyst upgrades
11/13/20 Stephens
Magellan Health upgraded to Overweight from Equal Weight at Stephens
RHHBY Roche
$0.00 /

+ (+0.00%)

11/11/20 Truist
Opthea initiated with a Buy at Truist
10/16/20 UBS
Roche price target lowered to CHF 370 from CHF 390 at UBS
10/06/20 Goldman Sachs
Goldman reiterates $34 target on Kiniksa after 'impressive' data
09/29/20 Berenberg
Roche initiated with a Hold at Berenberg
CARA Cara Therapeutics
$15.69 /

+0.28 (+1.82%)

10/20/20 H.C. Wainwright
Cara deal with 'perfect partner' Vifor boosts confidence at H.C. Wainwright
04/22/20 Cantor Fitzgerald
Cara Therapeutics price target raised to $34 from $26 at Cantor Fitzgerald
04/21/20 H.C. Wainwright
Cara Therapeutics price target raised to $33 from $30 at H.C. Wainwright
01/10/20 Stifel
Cara Therapeutics named a BioPharma top pick for 2020 at Stifel
IVA Inventiva
$14.00 /

-0.005 (-0.04%)

10/13/20 Roth Capital
Roth backs Buy on Inventiva after Lanifibranor given breakthrough designation
08/17/20 H.C. Wainwright
Inventiva price target raised to $38 from EUR 12 at H.C. Wainwright
08/05/20
Fly Intel: Top five analyst initiations
08/05/20 Roth Capital
Inventiva initiated with a Buy at Roth Capital
ITOS iTeos Therapeutics
$24.03 /

+0.36 (+1.52%)

10/07/20 Baird
iTeos Therapeutics initiated with an Outperform at Baird
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
09/01/20 Piper Sandler
iTeos Therapeutics heading for 'catalyst rich stretch', says Piper Sandler
08/18/20 SVB Leerink
SVB Leerink bullish on iTeos Therapeutics, initiates with an Outperform
CLBS Caladrius
$1.50 /

-0.01 (-0.66%)

05/22/20 Brookline
Caladrius initiated with a Buy at Brookline
05/18/20 Dawson James
Caladrius downgraded to Neutral from Buy at Dawson James
ALNA Allena Pharmaceuticals
$1.58 /

+0.07 (+4.64%)

10/01/20 B. Riley Securities
Allena Pharmaceuticals price target raised to $5 from $4 at B. Riley Securities
06/01/20 H.C. Wainwright
Allena Pharmaceuticals initiated with a Buy at H.C. Wainwright
03/18/20 Roth Capital
Allena Pharmaceuticals price target lowered to $11 from $31 at Roth Capital
02/12/20 Roth Capital
Streamlining makes Allena URIROX-2 path clear, says Roth Capital
SEEL Seelos Therapeutics
$0.82 /

-0.0299 (-3.52%)

09/09/20 Roth Capital
Seelos Therapeutics shares 'substantially undervalued,' says Roth Capital
06/23/20 Roth Capital
Seelos Therapeutics price target raised to $12 from $8 Roth Capital
11/18/19 H.C. Wainwright
Seelos Therapeutics price target lowered to $2 from $4 at H.C. Wainwright
SMMNY Siemens Healthineers
$0.00 /

+ (+0.00%)

11/10/20 Credit Suisse
Siemens Healthineers price target raised to EUR 44 from EUR 43 at Credit Suisse
10/28/20 Barrington
Varian Medical downgraded to Underperform from Outperform at Barrington
10/26/20 RBC Capital
Siemens Healthineers price target lowered to EUR 42 from EUR 45 at RBC Capital
10/06/20 Deutsche Bank
Siemens Healthineers price target lowered to EUR 39 at Deutsche Bank
CNCE Concert Pharmaceuticals
$11.01 /

-0.05 (-0.45%)

11/04/20 JMP Securities
Concert Pharmaceuticals resumed with an Outperform at JMP Securities
03/30/20
Fly Intel: Top five analyst initiations
03/30/20 Jefferies
Concert Pharmaceuticals initiated with a Buy at Jefferies
02/27/20 Stifel
Concert Pharmaceuticals price target raised to $11 from $8 at Stifel
SYNH Syneos Health
$63.82 /

+0.48 (+0.76%)

RHHBY Roche
$0.00 /

+ (+0.00%)

RDNT RadNet
$18.99 /

+0.43 (+2.32%)

PRTA Prothena
$12.37 /

+0.07 (+0.57%)

OPNT Opiant Pharmaceuticals
$7.83 /

+0.045 (+0.58%)

MRNA Moderna
$97.95 /

+8.65 (+9.69%)

MGLN Magellan Health
$85.23 /

+0.11 (+0.13%)

ITOS iTeos Therapeutics
$24.03 /

+0.36 (+1.52%)

INMD InMode
$41.88 /

-0.01 (-0.02%)

IMGN ImmunoGen
$5.75 /

-0.1 (-1.71%)

FGEN FibroGen
$43.03 /

+0.79 (+1.87%)

ESPR Esperion
$30.11 /

+1.45 (+5.06%)

CRL Charles River
$237.94 /

-0.75 (-0.31%)

CNCE Concert Pharmaceuticals
$11.01 /

-0.05 (-0.45%)

CLBS Caladrius
$1.50 /

-0.01 (-0.66%)

CARA Cara Therapeutics
$15.69 /

+0.28 (+1.82%)

AXGN AxoGen
$15.09 /

+0.445 (+3.04%)

ALNA Allena Pharmaceuticals
$1.58 /

+0.07 (+4.64%)

  • 16
    Sep
  • 24
    Jul
  • 10
    Jul
  • 19
    May
  • 12
    Mar
  • 11
    Feb
  • 12
    Feb
  • 28
    Jan
  • 21
    Jan
RHHBY Roche
$0.00 /

+ (+0.00%)

MRNA Moderna
$97.95 /

+8.65 (+9.69%)

SYNH Syneos Health
$63.82 /

+0.48 (+0.76%)

SMMNY Siemens Healthineers
$0.00 /

+ (+0.00%)

RHHBY Roche
$0.00 /

+ (+0.00%)

MRNA Moderna
$97.95 /

+8.65 (+9.69%)

IVA Inventiva
$14.00 /

-0.005 (-0.04%)

ITOS iTeos Therapeutics
$24.03 /

+0.36 (+1.52%)

IMGN ImmunoGen
$5.75 /

-0.1 (-1.71%)

FGEN FibroGen
$43.03 /

+0.79 (+1.87%)

ESPR Esperion
$30.11 /

+1.45 (+5.06%)

CARA Cara Therapeutics
$15.69 /

+0.28 (+1.82%)

AXGN AxoGen
$15.09 /

+0.445 (+3.04%)

MRNA Moderna
$97.95 /

+8.65 (+9.69%)

FGEN FibroGen
$43.03 /

+0.79 (+1.87%)

ESPR Esperion
$30.11 /

+1.45 (+5.06%)

Conference/Events
Stifel to hold a virtual conference » 04:55
11/17/20
11/17
04:55
11/17/20
04:55
SAGE

Sage Therapeutics

$73.51 /

-5.86 (-7.38%)

, EXAS

Exact Sciences

$121.29 /

-1.31 (-1.07%)

, QURE

uniQure

$43.93 /

+0.6 (+1.38%)

, LMAT

LeMaitre

$38.19 /

+1.22 (+3.30%)

, TRXC

TransEnterix

$0.42 /

+0.0095 (+2.31%)

, PRTA

Prothena

$12.37 /

+0.07 (+0.57%)

, IRIX

Iridex

$1.70 /

-0.09 (-5.03%)

, CARA

Cara Therapeutics

$15.69 /

+0.28 (+1.82%)

, CNCE

Concert Pharmaceuticals

$11.01 /

-0.05 (-0.45%)

, IVA

Inventiva

$14.00 /

-0.005 (-0.04%)

, NRIX

Nurix Therapeutics

$31.75 /

+2.46 (+8.40%)

, SPRO

Spero Therapeutics

$14.78 /

+0.41 (+2.85%)

, OM

Outset Medical

$60.88 /

+8.34 (+15.87%)

, AVNS

Avanos

$42.68 /

+0.63 (+1.50%)

, KIDS

OrthoPediatrics

$47.02 /

+0.2 (+0.43%)

, ZBH

Zimmer Biomet

$150.30 /

-1.08 (-0.71%)

, CBIO

Catalyst Biosciences

$5.97 /

+0.02 (+0.34%)

, FGEN

FibroGen

$43.03 /

+0.79 (+1.87%)

, PKI

PerkinElmer

$133.35 /

+1.07 (+0.81%)

Virtual Healthcare…

Virtual Healthcare Conference 2020 will be held on November 16-18.

ShowHide Related Items >><<
ZBH Zimmer Biomet
$150.30 /

-1.08 (-0.71%)

TRXC TransEnterix
$0.42 /

+0.0095 (+2.31%)

SPRO Spero Therapeutics
$14.78 /

+0.41 (+2.85%)

SAGE Sage Therapeutics
$73.51 /

-5.86 (-7.38%)

QURE uniQure
$43.93 /

+0.6 (+1.38%)

PRTA Prothena
$12.37 /

+0.07 (+0.57%)

PKI PerkinElmer
$133.35 /

+1.07 (+0.81%)

OM Outset Medical
$60.88 /

+8.34 (+15.87%)

NRIX Nurix Therapeutics
$31.75 /

+2.46 (+8.40%)

LMAT LeMaitre
$38.19 /

+1.22 (+3.30%)

KIDS OrthoPediatrics
$47.02 /

+0.2 (+0.43%)

IVA Inventiva
$14.00 /

-0.005 (-0.04%)

FGEN FibroGen
$43.03 /

+0.79 (+1.87%)

EXAS Exact Sciences
$121.29 /

-1.31 (-1.07%)

CNCE Concert Pharmaceuticals
$11.01 /

-0.05 (-0.45%)

CBIO Catalyst Biosciences
$5.97 /

+0.02 (+0.34%)

CARA Cara Therapeutics
$15.69 /

+0.28 (+1.82%)

AVNS Avanos
$42.68 /

+0.63 (+1.50%)

SAGE Sage Therapeutics
$73.51 /

-5.86 (-7.38%)

11/16/20
Fly Intel: Top five analyst downgrades
11/16/20 Morgan Stanley
Morgan Stanley downgrades Sage Therapeutics amid 'reasonable' expectations
11/16/20 Morgan Stanley
Sage Therapeutics downgraded to Equal Weight from Overweight at Morgan Stanley
11/11/20 Wedbush
Wedbush bullish on Praxis Precision Medicines, initiates with an Outperform
EXAS Exact Sciences
$121.29 /

-1.31 (-1.07%)

10/29/20
Fly Intel: Top five analyst downgrades
10/29/20 UBS
Exact Sciences downgraded to Neutral from Buy at UBS
10/28/20
Fly Intel: Top five analyst downgrades
10/28/20 Benchmark
Exact Sciences price target raised to $145 from $110 at Benchmark
QURE uniQure
$43.93 /

+0.6 (+1.38%)

11/11/20 Berenberg
Biotechnology companies initiated at Berenberg
11/11/20 Berenberg
uniQure initiated with a Buy at Berenberg
11/09/20 Jefferies
uniQure initiated with a Buy at Jefferies
11/04/20
Fly Intel: Top five analyst initiations
LMAT LeMaitre
$38.19 /

+1.22 (+3.30%)

10/30/20 Barrington
LeMaitre price target raised to $46 from $36 at Barrington
10/28/20 Barrington
Varian Medical downgraded to Underperform from Outperform at Barrington
07/24/20 Lake Street
LeMaitre price target raised to $38 from $33 at Lake Street
05/04/20 Roth Capital
LeMaitre price target lowered to $28 from $32.50 at Roth Capital
TRXC TransEnterix
$0.42 /

+0.0095 (+2.31%)

PRTA Prothena
$12.37 /

+0.07 (+0.57%)

10/21/20 Cantor Fitzgerald
Prothena price target raised to $24 from $20 at Cantor Fitzgerald
07/09/20 Oppenheimer
Prothena upgraded to Outperform at Oppenheimer
07/09/20 Oppenheimer
Prothena upgraded to Outperform from Perform at Oppenheimer
11/19/19 Evercore ISI
Prothena upgraded to Outperform on valuation at Evercore ISI
IRIX Iridex
$1.70 /

-0.09 (-5.03%)

CARA Cara Therapeutics
$15.69 /

+0.28 (+1.82%)

10/20/20 H.C. Wainwright
Cara deal with 'perfect partner' Vifor boosts confidence at H.C. Wainwright
04/22/20 Cantor Fitzgerald
Cara Therapeutics price target raised to $34 from $26 at Cantor Fitzgerald
04/21/20 H.C. Wainwright
Cara Therapeutics price target raised to $33 from $30 at H.C. Wainwright
01/10/20 Stifel
Cara Therapeutics named a BioPharma top pick for 2020 at Stifel
CNCE Concert Pharmaceuticals
$11.01 /

-0.05 (-0.45%)

11/04/20 JMP Securities
Concert Pharmaceuticals resumed with an Outperform at JMP Securities
03/30/20
Fly Intel: Top five analyst initiations
03/30/20 Jefferies
Concert Pharmaceuticals initiated with a Buy at Jefferies
02/27/20 Stifel
Concert Pharmaceuticals price target raised to $11 from $8 at Stifel
IVA Inventiva
$14.00 /

-0.005 (-0.04%)

10/13/20 Roth Capital
Roth backs Buy on Inventiva after Lanifibranor given breakthrough designation
08/17/20 H.C. Wainwright
Inventiva price target raised to $38 from EUR 12 at H.C. Wainwright
08/05/20
Fly Intel: Top five analyst initiations
08/05/20 Roth Capital
Inventiva initiated with a Buy at Roth Capital
NRIX Nurix Therapeutics
$31.75 /

+2.46 (+8.40%)

08/18/20
Fly Intel: Top five analyst initiations
08/18/20 JPMorgan
Nurix Therapeutics initiated with an Overweight at JPMorgan
08/18/20 Needham
Nurix Therapeutics initiated with a Buy at Needham
08/18/20 Stifel
Nurix Therapeutics initiated with a Buy at Stifel
SPRO Spero Therapeutics
$14.78 /

+0.41 (+2.85%)

09/29/20 Evercore ISI
Spero Therapeutics initiated with an Outperform at Evercore ISI
09/08/20 Stifel
Spero Therapeutics price target raised to $25 from $21 at Stifel
05/11/20 H.C. Wainwright
Spero Therapeutics price target raised to $28 from $25 at H.C. Wainwright
OM Outset Medical
$60.88 /

+8.34 (+15.87%)

10/12/20
Fly Intel: Top five analyst initiations
10/12/20 Morgan Stanley
Outset Medical initiated with an Equal Weight at Morgan Stanley
10/12/20 Stifel
Outset Medical initiated with a Buy at Stifel
10/12/20 SVB Leerink
Outset Medical initiated with a Market Perform at SVB Leerink
AVNS Avanos
$42.68 /

+0.63 (+1.50%)

04/13/20 Barclays
Avanos upgraded to Equal Weight from Underweight at Barclays
12/30/19 Stifel
Avanos makes 'welcome addition' with 'highly experienced' CFO, says Stifel
KIDS OrthoPediatrics
$47.02 /

+0.2 (+0.43%)

10/07/20 BTIG
OrthoPediatrics price target raised to $57 from $54 at BTIG
08/06/20 Piper Sandler
Piper says OrthoPediatrics can win in 'more muted competitive environment'
08/06/20 Needham
OrthoPediatrics price target raised to $57 from $49 at Needham
06/23/20 Piper Sandler
OrthoPediatrics recovery better than expected, says Piper Sandler
ZBH Zimmer Biomet
$150.30 /

-1.08 (-0.71%)

11/09/20 SVB Leerink
Zimmer Biomet price target raised to $167 from $160 at SVB Leerink
11/09/20 Credit Suisse
Zimmer Biomet price target raised to $106 from $99 at Credit Suisse
11/09/20 Baird
Zimmer Biomet valuation discount to peers hard to justify, says at Baird
11/09/20 Oppenheimer
Zimmer Biomet price target raised to $155 from $150 at Oppenheimer
CBIO Catalyst Biosciences
$5.97 /

+0.02 (+0.34%)

05/21/20 Raymond James
Catalyst Biosciences initiated with an Outperform at Raymond James
FGEN FibroGen
$43.03 /

+0.79 (+1.87%)

10/26/20 Raymond James
FibroGen initiated with an Underperform at Raymond James
10/26/20 Raymond James
FibroGen initiated with an Underperform at Raymond James
10/23/20 Stifel
FibroGen safety data mitigates concerns of roxadustat black box, says Stifel
09/04/20 Stifel
FibroGen's roxadustat can be 'dominant leader' as competitor fades, says Stifel
PKI PerkinElmer
$133.35 /

+1.07 (+0.81%)

11/09/20 KeyBanc
PerkinElmer initiated with a Sector Weight at KeyBanc
11/09/20 Needham
PerkinElmer price target raised to $193 from $139 at Needham
10/29/20 Wells Fargo
PerkinElmer price target raised to $140 from $130 at Wells Fargo
10/29/20 Baird
PerkinElmer price target raised to $151 from $137 at Baird
ZBH Zimmer Biomet
$150.30 /

-1.08 (-0.71%)

SPRO Spero Therapeutics
$14.78 /

+0.41 (+2.85%)

SAGE Sage Therapeutics
$73.51 /

-5.86 (-7.38%)

QURE uniQure
$43.93 /

+0.6 (+1.38%)

PRTA Prothena
$12.37 /

+0.07 (+0.57%)

PKI PerkinElmer
$133.35 /

+1.07 (+0.81%)

OM Outset Medical
$60.88 /

+8.34 (+15.87%)

NRIX Nurix Therapeutics
$31.75 /

+2.46 (+8.40%)

LMAT LeMaitre
$38.19 /

+1.22 (+3.30%)

KIDS OrthoPediatrics
$47.02 /

+0.2 (+0.43%)

IRIX Iridex
$1.70 /

-0.09 (-5.03%)

FGEN FibroGen
$43.03 /

+0.79 (+1.87%)

EXAS Exact Sciences
$121.29 /

-1.31 (-1.07%)

CNCE Concert Pharmaceuticals
$11.01 /

-0.05 (-0.45%)

CBIO Catalyst Biosciences
$5.97 /

+0.02 (+0.34%)

CARA Cara Therapeutics
$15.69 /

+0.28 (+1.82%)

AVNS Avanos
$42.68 /

+0.63 (+1.50%)

  • 11
    Sep
  • 15
    Sep
  • 24
    Jul
  • 10
    Jul
  • 18
    Jun
  • 18
    Jun
  • 13
    Feb
  • 28
    Jan
  • 11
    Dec
QURE uniQure
$43.93 /

+0.6 (+1.38%)

PKI PerkinElmer
$133.35 /

+1.07 (+0.81%)

SPRO Spero Therapeutics
$14.78 /

+0.41 (+2.85%)

QURE uniQure
$43.93 /

+0.6 (+1.38%)

PKI PerkinElmer
$133.35 /

+1.07 (+0.81%)

OM Outset Medical
$60.88 /

+8.34 (+15.87%)

NRIX Nurix Therapeutics
$31.75 /

+2.46 (+8.40%)

LMAT LeMaitre
$38.19 /

+1.22 (+3.30%)

KIDS OrthoPediatrics
$47.02 /

+0.2 (+0.43%)

IVA Inventiva
$14.00 /

-0.005 (-0.04%)

FGEN FibroGen
$43.03 /

+0.79 (+1.87%)

EXAS Exact Sciences
$121.29 /

-1.31 (-1.07%)

CBIO Catalyst Biosciences
$5.97 /

+0.02 (+0.34%)

CARA Cara Therapeutics
$15.69 /

+0.28 (+1.82%)

TRXC TransEnterix
$0.42 /

+0.0095 (+2.31%)

PKI PerkinElmer
$133.35 /

+1.07 (+0.81%)

FGEN FibroGen
$43.03 /

+0.79 (+1.87%)

EXAS Exact Sciences
$121.29 /

-1.31 (-1.07%)

Conference/Events
Stifel to hold a virtual conference » 09:48
11/16/20
11/16
09:48
11/16/20
09:48
SAGE

Sage Therapeutics

$76.51 /

-2.86 (-3.60%)

, EXAS

Exact Sciences

$123.67 /

+1.07 (+0.87%)

, QURE

uniQure

$43.29 /

-0.04 (-0.09%)

, LMAT

LeMaitre

$37.00 /

+0.03 (+0.08%)

, TRXC

TransEnterix

$0.43 /

+0.0172 (+4.17%)

, PRTA

Prothena

$12.30 /

+ (+0.00%)

, IRIX

Iridex

$1.79 /

+ (+0.00%)

, CARA

Cara Therapeutics

$15.47 /

+0.06 (+0.39%)

, CNCE

Concert Pharmaceuticals

$11.01 /

-0.05 (-0.45%)

, IVA

Inventiva

$14.01 /

+ (+0.00%)

, NRIX

Nurix Therapeutics

$29.44 /

+0.15 (+0.51%)

, SPRO

Spero Therapeutics

$14.36 /

-0.01 (-0.07%)

, OM

Outset Medical

$53.00 /

+0.46 (+0.88%)

, AVNS

Avanos

$42.93 /

+0.88 (+2.09%)

, KIDS

OrthoPediatrics

$46.79 /

-0.03 (-0.06%)

, ZBH

Zimmer Biomet

$153.10 /

+1.72 (+1.14%)

, CBIO

Catalyst Biosciences

$5.96 /

+0.01 (+0.17%)

, FGEN

FibroGen

$42.48 /

+0.24 (+0.57%)

, PKI

PerkinElmer

$132.20 /

-0.08 (-0.06%)

Virtual Healthcare…

Virtual Healthcare Conference 2020 will be held on November 16-18.

ShowHide Related Items >><<
ZBH Zimmer Biomet
$153.10 /

+1.72 (+1.14%)

TRXC TransEnterix
$0.43 /

+0.0172 (+4.17%)

SPRO Spero Therapeutics
$14.36 /

-0.01 (-0.07%)

SAGE Sage Therapeutics
$76.51 /

-2.86 (-3.60%)

QURE uniQure
$43.29 /

-0.04 (-0.09%)

PRTA Prothena
$12.30 /

+ (+0.00%)

PKI PerkinElmer
$132.20 /

-0.08 (-0.06%)

OM Outset Medical
$53.00 /

+0.46 (+0.88%)

NRIX Nurix Therapeutics
$29.44 /

+0.15 (+0.51%)

LMAT LeMaitre
$37.00 /

+0.03 (+0.08%)

KIDS OrthoPediatrics
$46.79 /

-0.03 (-0.06%)

IVA Inventiva
$14.01 /

+ (+0.00%)

FGEN FibroGen
$42.48 /

+0.24 (+0.57%)

EXAS Exact Sciences
$123.67 /

+1.07 (+0.87%)

CNCE Concert Pharmaceuticals
$11.01 /

-0.05 (-0.45%)

CBIO Catalyst Biosciences
$5.96 /

+0.01 (+0.17%)

CARA Cara Therapeutics
$15.47 /

+0.06 (+0.39%)

AVNS Avanos
$42.93 /

+0.88 (+2.09%)

SAGE Sage Therapeutics
$76.51 /

-2.86 (-3.60%)

11/16/20 Morgan Stanley
Morgan Stanley downgrades Sage Therapeutics amid 'reasonable' expectations
11/16/20 Morgan Stanley
Sage Therapeutics downgraded to Equal Weight from Overweight at Morgan Stanley
11/11/20 Wedbush
Wedbush bullish on Praxis Precision Medicines, initiates with an Outperform
11/10/20 Truist
Sage Therapeutics price target raised to $60 from $35 at Truist
EXAS Exact Sciences
$123.67 /

+1.07 (+0.87%)

10/29/20
Fly Intel: Top five analyst downgrades
10/29/20 UBS
Exact Sciences downgraded to Neutral from Buy at UBS
10/28/20
Fly Intel: Top five analyst downgrades
10/28/20 Benchmark
Exact Sciences price target raised to $145 from $110 at Benchmark
QURE uniQure
$43.29 /

-0.04 (-0.09%)

11/11/20 Berenberg
Biotechnology companies initiated at Berenberg
11/11/20 Berenberg
uniQure initiated with a Buy at Berenberg
11/09/20 Jefferies
uniQure initiated with a Buy at Jefferies
11/04/20
Fly Intel: Top five analyst initiations
LMAT LeMaitre
$37.00 /

+0.03 (+0.08%)

10/30/20 Barrington
LeMaitre price target raised to $46 from $36 at Barrington
10/28/20 Barrington
Varian Medical downgraded to Underperform from Outperform at Barrington
07/24/20 Lake Street
LeMaitre price target raised to $38 from $33 at Lake Street
05/04/20 Roth Capital
LeMaitre price target lowered to $28 from $32.50 at Roth Capital
TRXC TransEnterix
$0.43 /

+0.0172 (+4.17%)

PRTA Prothena
$12.30 /

+ (+0.00%)

10/21/20 Cantor Fitzgerald
Prothena price target raised to $24 from $20 at Cantor Fitzgerald
07/09/20 Oppenheimer
Prothena upgraded to Outperform at Oppenheimer
07/09/20 Oppenheimer
Prothena upgraded to Outperform from Perform at Oppenheimer
11/19/19 Evercore ISI
Prothena upgraded to Outperform on valuation at Evercore ISI
IRIX Iridex
$1.79 /

+ (+0.00%)

CARA Cara Therapeutics
$15.47 /

+0.06 (+0.39%)

10/20/20 H.C. Wainwright
Cara deal with 'perfect partner' Vifor boosts confidence at H.C. Wainwright
04/22/20 Cantor Fitzgerald
Cara Therapeutics price target raised to $34 from $26 at Cantor Fitzgerald
04/21/20 H.C. Wainwright
Cara Therapeutics price target raised to $33 from $30 at H.C. Wainwright
01/10/20 Stifel
Cara Therapeutics named a BioPharma top pick for 2020 at Stifel
CNCE Concert Pharmaceuticals
$11.01 /

-0.05 (-0.45%)

11/04/20 JMP Securities
Concert Pharmaceuticals resumed with an Outperform at JMP Securities
03/30/20
Fly Intel: Top five analyst initiations
03/30/20 Jefferies
Concert Pharmaceuticals initiated with a Buy at Jefferies
02/27/20 Stifel
Concert Pharmaceuticals price target raised to $11 from $8 at Stifel
IVA Inventiva
$14.01 /

+ (+0.00%)

10/13/20 Roth Capital
Roth backs Buy on Inventiva after Lanifibranor given breakthrough designation
08/17/20 H.C. Wainwright
Inventiva price target raised to $38 from EUR 12 at H.C. Wainwright
08/05/20
Fly Intel: Top five analyst initiations
08/05/20 Roth Capital
Inventiva initiated with a Buy at Roth Capital
NRIX Nurix Therapeutics
$29.44 /

+0.15 (+0.51%)

08/18/20
Fly Intel: Top five analyst initiations
08/18/20 JPMorgan
Nurix Therapeutics initiated with an Overweight at JPMorgan
08/18/20 Needham
Nurix Therapeutics initiated with a Buy at Needham
08/18/20 Stifel
Nurix Therapeutics initiated with a Buy at Stifel
SPRO Spero Therapeutics
$14.36 /

-0.01 (-0.07%)

09/29/20 Evercore ISI
Spero Therapeutics initiated with an Outperform at Evercore ISI
09/08/20 Stifel
Spero Therapeutics price target raised to $25 from $21 at Stifel
05/11/20 H.C. Wainwright
Spero Therapeutics price target raised to $28 from $25 at H.C. Wainwright
OM Outset Medical
$53.00 /

+0.46 (+0.88%)

10/12/20
Fly Intel: Top five analyst initiations
10/12/20 Morgan Stanley
Outset Medical initiated with an Equal Weight at Morgan Stanley
10/12/20 Stifel
Outset Medical initiated with a Buy at Stifel
10/12/20 SVB Leerink
Outset Medical initiated with a Market Perform at SVB Leerink
AVNS Avanos
$42.93 /

+0.88 (+2.09%)

04/13/20 Barclays
Avanos upgraded to Equal Weight from Underweight at Barclays
12/30/19 Stifel
Avanos makes 'welcome addition' with 'highly experienced' CFO, says Stifel
KIDS OrthoPediatrics
$46.79 /

-0.03 (-0.06%)

10/07/20 BTIG
OrthoPediatrics price target raised to $57 from $54 at BTIG
08/06/20 Piper Sandler
Piper says OrthoPediatrics can win in 'more muted competitive environment'
08/06/20 Needham
OrthoPediatrics price target raised to $57 from $49 at Needham
06/23/20 Piper Sandler
OrthoPediatrics recovery better than expected, says Piper Sandler
ZBH Zimmer Biomet
$153.10 /

+1.72 (+1.14%)

11/09/20 SVB Leerink
Zimmer Biomet price target raised to $167 from $160 at SVB Leerink
11/09/20 Credit Suisse
Zimmer Biomet price target raised to $106 from $99 at Credit Suisse
11/09/20 Baird
Zimmer Biomet valuation discount to peers hard to justify, says at Baird
11/09/20 Oppenheimer
Zimmer Biomet price target raised to $155 from $150 at Oppenheimer
CBIO Catalyst Biosciences
$5.96 /

+0.01 (+0.17%)

05/21/20 Raymond James
Catalyst Biosciences initiated with an Outperform at Raymond James
FGEN FibroGen
$42.48 /

+0.24 (+0.57%)

10/26/20 Raymond James
FibroGen initiated with an Underperform at Raymond James
10/26/20 Raymond James
FibroGen initiated with an Underperform at Raymond James
10/23/20 Stifel
FibroGen safety data mitigates concerns of roxadustat black box, says Stifel
09/04/20 Stifel
FibroGen's roxadustat can be 'dominant leader' as competitor fades, says Stifel
PKI PerkinElmer
$132.20 /

-0.08 (-0.06%)

11/09/20 KeyBanc
PerkinElmer initiated with a Sector Weight at KeyBanc
11/09/20 Needham
PerkinElmer price target raised to $193 from $139 at Needham
10/29/20 Wells Fargo
PerkinElmer price target raised to $140 from $130 at Wells Fargo
10/29/20 Baird
PerkinElmer price target raised to $151 from $137 at Baird
ZBH Zimmer Biomet
$153.10 /

+1.72 (+1.14%)

SPRO Spero Therapeutics
$14.36 /

-0.01 (-0.07%)

SAGE Sage Therapeutics
$76.51 /

-2.86 (-3.60%)

QURE uniQure
$43.29 /

-0.04 (-0.09%)

PRTA Prothena
$12.30 /

+ (+0.00%)

PKI PerkinElmer
$132.20 /

-0.08 (-0.06%)

OM Outset Medical
$53.00 /

+0.46 (+0.88%)

NRIX Nurix Therapeutics
$29.44 /

+0.15 (+0.51%)

LMAT LeMaitre
$37.00 /

+0.03 (+0.08%)

KIDS OrthoPediatrics
$46.79 /

-0.03 (-0.06%)

IRIX Iridex
$1.79 /

+ (+0.00%)

FGEN FibroGen
$42.48 /

+0.24 (+0.57%)

EXAS Exact Sciences
$123.67 /

+1.07 (+0.87%)

CNCE Concert Pharmaceuticals
$11.01 /

-0.05 (-0.45%)

CBIO Catalyst Biosciences
$5.96 /

+0.01 (+0.17%)

CARA Cara Therapeutics
$15.47 /

+0.06 (+0.39%)

AVNS Avanos
$42.93 /

+0.88 (+2.09%)

  • 11
    Sep
  • 15
    Sep
  • 24
    Jul
  • 10
    Jul
  • 18
    Jun
  • 18
    Jun
  • 13
    Feb
  • 28
    Jan
  • 11
    Dec
QURE uniQure
$43.29 /

-0.04 (-0.09%)

PKI PerkinElmer
$132.20 /

-0.08 (-0.06%)

SPRO Spero Therapeutics
$14.36 /

-0.01 (-0.07%)

QURE uniQure
$43.29 /

-0.04 (-0.09%)

PKI PerkinElmer
$132.20 /

-0.08 (-0.06%)

OM Outset Medical
$53.00 /

+0.46 (+0.88%)

NRIX Nurix Therapeutics
$29.44 /

+0.15 (+0.51%)

LMAT LeMaitre
$37.00 /

+0.03 (+0.08%)

KIDS OrthoPediatrics
$46.79 /

-0.03 (-0.06%)

IVA Inventiva
$14.01 /

+ (+0.00%)

FGEN FibroGen
$42.48 /

+0.24 (+0.57%)

EXAS Exact Sciences
$123.67 /

+1.07 (+0.87%)

CBIO Catalyst Biosciences
$5.96 /

+0.01 (+0.17%)

CARA Cara Therapeutics
$15.47 /

+0.06 (+0.39%)

TRXC TransEnterix
$0.43 /

+0.0172 (+4.17%)

PKI PerkinElmer
$132.20 /

-0.08 (-0.06%)

FGEN FibroGen
$42.48 /

+0.24 (+0.57%)

EXAS Exact Sciences
$123.67 /

+1.07 (+0.87%)

Conference/Events
Prothena management to meet virtually with Cantor Fitzgerald » 04:55
11/13/20
11/13
04:55
11/13/20
04:55
PRTA

Prothena

$12.36 /

-0.03 (-0.24%)

Virtual Meetings to be…

Virtual Meetings to be held November 10-13 hosted by Cantor Fitzgerald.

ShowHide Related Items >><<
PRTA Prothena
$12.36 /

-0.03 (-0.24%)

PRTA Prothena
$12.36 /

-0.03 (-0.24%)

10/21/20 Cantor Fitzgerald
Prothena price target raised to $24 from $20 at Cantor Fitzgerald
07/09/20 Oppenheimer
Prothena upgraded to Outperform at Oppenheimer
07/09/20 Oppenheimer
Prothena upgraded to Outperform from Perform at Oppenheimer
11/19/19 Evercore ISI
Prothena upgraded to Outperform on valuation at Evercore ISI
PRTA Prothena
$12.36 /

-0.03 (-0.24%)

Conference/Events
Prothena management to meet virtually with Cantor Fitzgerald » 05:55
11/12/20
11/12
05:55
11/12/20
05:55
PRTA

Prothena

$12.38 /

+0.03 (+0.24%)

Virtual Meetings to be…

Virtual Meetings to be held November 10-13 hosted by Cantor Fitzgerald.

ShowHide Related Items >><<
PRTA Prothena
$12.38 /

+0.03 (+0.24%)

PRTA Prothena
$12.38 /

+0.03 (+0.24%)

10/21/20 Cantor Fitzgerald
Prothena price target raised to $24 from $20 at Cantor Fitzgerald
07/09/20 Oppenheimer
Prothena upgraded to Outperform at Oppenheimer
07/09/20 Oppenheimer
Prothena upgraded to Outperform from Perform at Oppenheimer
11/19/19 Evercore ISI
Prothena upgraded to Outperform on valuation at Evercore ISI
PRTA Prothena
$12.38 /

+0.03 (+0.24%)

PRTA Prothena
$12.38 /

+0.03 (+0.24%)

Conference/Events
Prothena management to meet virtually with Cantor Fitzgerald » 04:55
11/11/20
11/11
04:55
11/11/20
04:55
PRTA

Prothena

$12.35 /

+0.1 (+0.82%)

Virtual Meetings to be…

Virtual Meetings to be held November 10-13 hosted by Cantor Fitzgerald.

ShowHide Related Items >><<
PRTA Prothena
$12.35 /

+0.1 (+0.82%)

PRTA Prothena
$12.35 /

+0.1 (+0.82%)

10/21/20 Cantor Fitzgerald
Prothena price target raised to $24 from $20 at Cantor Fitzgerald
07/09/20 Oppenheimer
Prothena upgraded to Outperform at Oppenheimer
07/09/20 Oppenheimer
Prothena upgraded to Outperform from Perform at Oppenheimer
11/19/19 Evercore ISI
Prothena upgraded to Outperform on valuation at Evercore ISI
PRTA Prothena
$12.35 /

+0.1 (+0.82%)

PRTA Prothena
$12.35 /

+0.1 (+0.82%)

Conference/Events
Prothena management to meet virtually with Cantor Fitzgerald » 13:26
11/10/20
11/10
13:26
11/10/20
13:26
PRTA

Prothena

$12.62 /

+0.37 (+3.02%)

Virtual Meetings to be…

Virtual Meetings to be held November 10-13 hosted by Cantor Fitzgerald.

ShowHide Related Items >><<
PRTA Prothena
$12.62 /

+0.37 (+3.02%)

PRTA Prothena
$12.62 /

+0.37 (+3.02%)

10/21/20 Cantor Fitzgerald
Prothena price target raised to $24 from $20 at Cantor Fitzgerald
07/09/20 Oppenheimer
Prothena upgraded to Outperform at Oppenheimer
07/09/20 Oppenheimer
Prothena upgraded to Outperform from Perform at Oppenheimer
11/19/19 Evercore ISI
Prothena upgraded to Outperform on valuation at Evercore ISI
PRTA Prothena
$12.62 /

+0.37 (+3.02%)

PRTA Prothena
$12.62 /

+0.37 (+3.02%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.